Skip to main content

Corona Virus Infection clinical trials at UCSF

2 research studies open to eligible people

Showing trials for
  • Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic

    open to eligible females ages 18 years and up

    Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

    San Francisco, California

  • Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

    open to eligible people ages 40 years and up

    This is a phase 3, multi-center, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection and have at least one high-risk criterion. Approximately 6000 subjects meeting all inclusion and no exclusion criteria will be randomized to receive either colchicine or placebo tablets for 30 days.

    San Francisco, California and other locations

Last updated: